0.2984
110.14%
0.1564
Dopo l'orario di chiusura:
.20
-0.0984
-32.98%
Aclarion Inc Borsa (ACON) Ultime notizie
Aclarion, Inc. ends sales agreement with Ascendiant Capital - Investing.com India
Aclarion, Inc. shareholders approve key proposals at annual meeting By Investing.com - Investing.com Nigeria
Breaking News: Aclarion’s Game-Changing Stock Sale! Discover How They're Revolutionizing Back Pain Treatment. - elblog.pl
Aclarion, Inc. ends sales agreement with Ascendiant Capital By Investing.com - Investing.com Nigeria
Aclarion, Inc. shareholders approve key proposals at annual meeting - Investing.com
Aclarion Announces Pricing of Registered Direct Offering of Common Stock Priced at the Market - Yahoo Finance
Aclarion, Inc. Ends Sales Agreement with Ascendiant - TipRanks
Sheridan hospital selected for rural health project - Greenville Daily News
Salesforce (NYSE:CRM) Stock Price Down 1.1% Following Insider Selling - Defense World
Rivian Automotive (NASDAQ:RIVN) Stock Price Down 2.1% on Insider Selling - Defense World
Arch Capital Group Ltd. (NASDAQ:ACGLN) Short Interest Update - Defense World
Red Cat (NASDAQ:RCAT) Trading Down 7.1% Following Insider Selling - Defense World
Enfusion (NYSE:ENFN) Shares Gap Down Following Insider Selling - Defense World
Short Interest in Able View Global Inc. (NASDAQ:ABLV) Grows By 33.6% - Defense World
Progyny (NASDAQ:PGNY) Shares Gap Up After Insider Buying Activity - Defense World
SoundHound AI (NASDAQ:SOUN) Shares Down 1.7% on Insider Selling - Defense World
Aclarion stock hits 52-week low at $0.1 amid sharp annual decline - Investing.com India
Aclarion stock hits 52-week low at $0.1 amid sharp annual decline By Investing.com - Investing.com South Africa
COP29's Green Digital Action Pledge is a clarion call to rethink how we use AI and Big Data - BusinessGreen
Aclarion (ACON) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
Aclarion (NASDAQ:ACON) Earns Hold Rating from Maxim Group - Defense World
Maxim Group Downgrades Aclarion (ACON) - MSN
Aclarion stock hits 52-week low at $0.15 amid sharp annual decline By Investing.com - Investing.com South Africa
Aclarion stock hits 52-week low at $0.15 amid sharp annual decline - Investing.com
Winter 2024 Investor Summit Virtual: Q4 Presentations Now Available for On-Demand Viewing - AccessWire
Forum Energy Technologies Inc (FET-N) QuotePress Release - The Globe and Mail
Steel Partners (NYSE:SPLP) Shares Gap Down – What’s Next? - Defense World
This bizarre movie about beavers is a clarion call for human creativity in the age of AI - San Francisco Chronicle
Aclarion extends equity line agreement, issues new shares - Investing.com
Aclarion extends equity line agreement, issues new shares By Investing.com - Investing.com Canada
TELUS (TSE:T) Price Target Lowered to C$23.25 at Scotiabank - Defense World
On Constitution Day, Kharge makes a clarion call to bring back ballot papers - Deccan Herald
Aclarion Announces Nociscan Featured in RSNA Edition of Siemens MAGNETOM Flash - OrthoSpineNews
Aclarion's Nociscan Pain Detection Platform Featured in Siemens Healthineers Magazine | ACON Stock News - StockTitan
‘We need to fight': Diego Luna's latest a clarion call to protect journalists - Yeni Şafak English
Aclarion, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Aclarion Inc (ACON) Quarterly 10-Q Report - Quartzy
Aclarion to Present at the Virtual Investor Summit Microcap Event on November 21st - WICZ
Aclarion to Present at Virtual Investor Summit: AI-Driven Back Pain Tech in Focus | ACON Stock News - StockTitan
Agilon Health (AGL) Reports Q3 Loss, Lags Revenue Estimates - MSN
US Stocks Mixed; Core PCE Prices Rise In December - MSN
Sheridan Community Hospital celebrates 80th Anniversary on Nov. 9 - Greenville Daily News
Opinion: Queensland election a clarion call for coal miners - Mining.com.au
Intervertebral Disc Magnetic Resonance Spectroscopy Changes After Spinal Manipulative Therapy for Lumbar Discogenic Pain - Cureus
Sunitha Sarathy’s ‘Had Enough‘ is a clarion call to women to reclaim their position in society - The Hindu
Critical Analysis: MDxHealth (NASDAQ:MDXH) & Aclarion (NASDAQ:ACON) - Defense World
Aclarion’s Nociscan Technology Enhances Understanding of Modic Changes in Back Pain Patients - MSN
Aclarion, Inc. faces Nasdaq delisting over compliance issues By Investing.com - Investing.com Australia
Aclarion, Inc. faces Nasdaq delisting over compliance issues - Investing.com India
Aclarion CEO to Present at 2024 Maxim Healthcare Virtual Summit - Vancity Buzz
Aclarion to Participate in the 2024 Maxim Healthcare Virtual Summit - The Manila Times
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):